Early Implementation of QbD in Biopharmaceutical Development: A Practical Example
In drug development, the “onus” of the low R&D efficiency has been put traditionally onto the drug discovery process (i.e., finding the right target or “binding” functionality). Here, we show that manufacturing is not only a central component of product success, but also that, by integrating ma...
Main Authors: | Jesús Zurdo, Andreas Arnell, Olga Obrezanova, Noel Smith, Ramón Gómez de la Cuesta, Thomas R. A. Gallagher, Rebecca Michael, Yvette Stallwood, Caroline Ekblad, Lars Abrahmsén, Ingmarie Höidén-Guthenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/605427 |
Similar Items
-
QbD not QED
by: Shireesh Apte -
QbD not QED
by: Shireesh Apte
Published: (2011-09-01) -
QbD: The cost of doing business
by: Shireesh Apte -
Comparative Analysis of the QbD Approach in the Pharmaceutical Industry
by: S. A. Rozhnova, et al.
Published: (2019-11-01) -
An Integrated Downstream Process Development Strategy along QbD Principles
by: Andrea Meitz, et al.
Published: (2014-10-01)